Search

everythinglearnresearchcommunity

for

Search:↓

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Balding men have harder scalps.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The study created a new hair loss treatment paste that regrows hair faster and with fewer side effects than minoxidil alone.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

Microneedling therapy is effective and safe for treating hair disorders worsened by COVID-19.

Some nutritional supplements may help thicken hair in people with hair loss, but taking too much can cause side effects.

Stem cell therapies show promise for hair regrowth but need more research to confirm effectiveness.

PRP may help with hair loss and improve hair quality with few side effects, but more research is needed.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

In Pakistan, men with more severe hair loss often have a higher BMI.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Men with higher body mass index (BMI) in Taiwan tend to have more severe hair loss.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

PRP might help with hair growth, but the evidence is weak.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.